| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 09/23/2008 | CA2445687C Compositions, methods and systems for the discovery of enediyne natural products |
| 09/23/2008 | CA2346797C Process for recovering heterologous polypeptides from bacterial cells |
| 09/23/2008 | CA2332126C A novel human thrombopoietin mutein |
| 09/23/2008 | CA2259940C High-affinity interleukin-4 muteins |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/23/2008 | CA2169852C Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 09/23/2008 | CA2143125C Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 09/18/2008 | WO2008112092A2 Production of glycoproteins with modified fucosylation |
| 09/18/2008 | WO2008111634A1 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 09/18/2008 | WO2008111613A1 Endoglucanase ppce and cellulase preparation containing the same |
| 09/18/2008 | WO2008110653A1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof |
| 09/18/2008 | WO2008036970A3 Insulin-degrading enzyme mutants and methods of use |
| 09/18/2008 | WO2007092932A3 Bivalent erbb ligand binding molecules and methods for their preparation and use |
| 09/18/2008 | US20080229455 Using vector transformation to generate plant with enhanced carbohydrate content; improving fruit sweetness |
| 09/18/2008 | US20080229446 Expression vector comprising nucleotide sequences coding isomerase for use in generating plants with enhanced isoprenoid biosynthesis |
| 09/18/2008 | US20080229438 Plasmid comprising nucleotide sequences coding human growth hormone for use in transformation and propagation in bovine embryos; bioreactors |
| 09/18/2008 | US20080227975 Method of producing fr901228 |
| 09/18/2008 | US20080227959 Immunogenic compounds for producing antibodies to efavirenz; monoclonal antibodies; immunoassays for selectively determining efavirenz levels in plasma; treatment failure and central nervous system side effects due to low and high plasma levels, respectively |
| 09/18/2008 | US20080227955 Nematode PAN and ZP Receptor-Like Sequences |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227737 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 09/18/2008 | US20080227713 amino acid sequence of Ser1-Pro2-Lys3-Met4-Val5-Gln6-Gly7-Ser8-Gly9-Cys10-Phe11-Gly12-Arg13-Lys14-Met15-Asp16-Arg17-Ile18-Ser19-Ser20-Ser21-Ser22-Gly23-Leu24-Gly25-Cys26-Lys27-Val28-Leu29-Arg30-Lys31-His32, either Met4, Met15, or both are oxidized; diagnosis heart failure |
| 09/18/2008 | US20080227712 Polypeptide for use in treatment and prevention of leukemia, hemophilia and nervous system disorders |
| 09/18/2008 | US20080227711 Cxc-Chemokine Antagonists |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227704 CXCL13 binding proteins |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227195 Expanding the eukaryotic genetic code |
| 09/18/2008 | US20080227158 Novel polypeptide, novel dna and novel antibody |
| 09/18/2008 | US20080227157 Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227155 Pegylated soluble gp130-dimers useful as a medicament |
| 09/18/2008 | US20080227154 Protein Expression |
| 09/18/2008 | US20080227153 Site specific incorporation of keto amino acids into proteins |
| 09/18/2008 | US20080227152 In vivo incorporation of unnatural amino acids |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227148 Aspergillus Promotors for Expressing a Gene in a Fungal Cell |
| 09/18/2008 | US20080227147 Lysosomal enzyme for use in destroying clostridial bacteria in chesse and milk products; improving food processing |
| 09/18/2008 | US20080227146 Immortalized Avian Cell Lines For Virus Production |
| 09/18/2008 | US20080227145 Filamentous Fungal Mutants With Improved Homologous Recombination Efficiency |
| 09/18/2008 | US20080227136 Cell culture improvements |
| 09/18/2008 | US20080227132 Hydrolase Enzymes and Their Use in Kinetic Resolution |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227123 Methods for Specifically Selecting Antibody-Producing Cells |
| 09/18/2008 | US20080227122 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/18/2008 | US20080227110 Expression vector comprising nucleotide sequences coding human polypeptide for use in treatment of metabolic disorders; immunotherapy |
| 09/18/2008 | US20080227106 Compositions and methods for the diagnosis and treatment of tumor |
| 09/18/2008 | US20080227085 Methods and Systems for the Identification of Rna Regulatory Sequences and Compounds that Modulate their Function |
| 09/18/2008 | US20080226681 Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226634 Tes7 and antibodies that bind thereto |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |
| 09/18/2008 | US20080226621 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226617 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226597 Viricidal protein for prevention and treatment of hepatitis infection |
| 09/18/2008 | US20080226586 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 09/18/2008 | US20080226558 Mesoderm and definitive endoderm cell populations |
| 09/18/2008 | DE102007013238A1 Process for utilizing protein containing sludges from breweries, distilleries and other food enterprises, comprises conversion of protease or lactose to lactic acid and proteins to oligopeptides by lactic acid bacterium |
| 09/18/2008 | CA2680656A1 Endoglucanase ppce and cellulase preparation containing the same |
| 09/18/2008 | CA2680613A1 Methods for generation of antibodies |
| 09/18/2008 | CA2679732A1 Production of glycoproteins with modified fucosylation |
| 09/17/2008 | EP1970707A1 Method for detection of virulent strain of influenza type-a virus |
| 09/17/2008 | EP1970448A1 Human artificial chromosome containting human antibody lambda light chain and non-human animal containting the human artificial chromosome capable of genetic transmission |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies |
| 09/17/2008 | EP1969591A1 A method for inclusion of psychological temperament in an electornic emulation of the human brain |
| 09/17/2008 | EP1969175A1 A novel catalytic reactor process for the production of commercial grade pulp, native lignin and unicellular protein |
| 09/17/2008 | EP1969165A1 Methods for generating and screening fusion protein libraries and uses thereof |
| 09/17/2008 | EP1969144A2 Compositions and methods related to controlled gene expression using viral vectors |
| 09/17/2008 | EP1969127A2 Method of producing biologically active vitamin k dependent proteins by recombinant methods |
| 09/17/2008 | EP1859046A4 Expression vector for animal cell comprising at least one copy of mar dna sequences at the 3'terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector |
| 09/17/2008 | EP1476563B1 Method for the recombination of genetic elements |
| 09/17/2008 | EP1412747B1 Method and antibody for detecting alcohol consumption |
| 09/17/2008 | EP1409692B1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 09/17/2008 | EP1380646B1 Acetyllysine-recognizing monoclonal antibody and process for producing the same |
| 09/17/2008 | EP1364005B1 A method for evolving a cell having desired phenotype and evolved cells |
| 09/17/2008 | EP1305334B1 Urocortin proteins and uses thereof |
| 09/17/2008 | EP1253941B1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 09/17/2008 | EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof |
| 09/17/2008 | EP1066328B1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
| 09/17/2008 | EP1062333B1 Chondrosarcoma associated genes |
| 09/17/2008 | EP1017714B1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |
| 09/17/2008 | EP0994951B1 Polynucleotides and their use for detecting resistance to streptogramin a |
| 09/17/2008 | EP0859852B1 Commercial production of aprotinin in plants |
| 09/17/2008 | EP0832116B1 New dna molecules |
| 09/17/2008 | CN101268097A Method for amidating polypeptides with basic aminoacid C- terminals by means of specific endoproteases |
| 09/17/2008 | CN101265503A Label for distinguishing mesenchymal stem cells and method for distinguishing mesenchymal stem cells using the same |
| 09/17/2008 | CN101265468A Method for preparing protein kinase, active peptide and proteinase from spirulina |
| 09/17/2008 | CN101265300A Small molecule recombination toxin GnRH-luffinS2 fusion albumen and its preparation and application |
| 09/17/2008 | CN100419079C Compositions and methods for therapy and diagnosis of prostate cancer |